PCI-27483: Clinical Trials

1 trial of PCI-27483, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow PCI-27483: new trials by email Literature Review of PCI-27483 trials Research Report on PCI-27483

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
PCI-27483, Gemcitabine - Pancreatic Cancer, Ductal Adrenocarcinoma
Phase 2CompletedPharmacyclics LLC.422009-11-012014-04-24

Conditions studied

Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Pharmacyclics LLC. (1)

Countries

United States (1)

Top investigators

Eric Hedrick, MD (1)  ·  Laurence Elias, MD (1)